• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用张量分解对他汀类药物中等强度治疗效果优于预期的韩国患者进行表型分析。

Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization.

机构信息

Department of Computer Science and Engineering, Pohang University of Science and Technology, Pohang, Republic of Korea.

Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

PLoS One. 2018 Jun 13;13(6):e0197518. doi: 10.1371/journal.pone.0197518. eCollection 2018.

DOI:10.1371/journal.pone.0197518
PMID:29897980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5999101/
Abstract

Several studies have been conducted to evaluate the efficacy of statins in Korean and Asian patients. However, most previous studies only observed the percent reduction in low-density lipoprotein cholesterol (LDL-C) and did not consider the effects of various patient conditions simultaneously, such as abnormal test results, patient demographics, and prescribed drugs before taking a statin. Moreover, the characteristics of the patients whose percent reduction in LDL-C was higher than expected were not provided. Therefore, in this study, we aimed to derive meaningful phenotypes by using tensor factorization to observe the characteristics of the patients whose percent reduction in LDL-C was higher than expected among patients taking moderate-intensity statins. In addition, we used the derived phenotypes to predict how much the LDL-C levels of new patients decreased. We consequently identified eight phenotypes that represented the characteristics of the patients whose percent reduction in LDL-C was higher than expected. Moreover, the latent representations of the derived phenotypes achieved prediction performance similar to that obtained using the raw data. These results demonstrate that the derived phenotypes and latent representations are useful tools for observing the characteristics of patients and predicting LDL-C levels. Additionally, our findings provide direction on how to conduct clinical studies in the future.

摘要

已经有几项研究评估了他汀类药物在韩国和亚洲患者中的疗效。然而,大多数先前的研究仅观察了低密度脂蛋白胆固醇(LDL-C)的降低百分比,并没有同时考虑各种患者情况的影响,如异常的测试结果、患者人口统计学特征以及服用他汀类药物前的处方药物。此外,还没有提供 LDL-C 降低百分比高于预期的患者的特征。因此,在这项研究中,我们旨在通过使用张量分解来推导有意义的表型,以观察服用中等强度他汀类药物的患者中 LDL-C 降低百分比高于预期的患者的特征。此外,我们使用推导的表型来预测新患者的 LDL-C 水平降低多少。我们最终确定了 8 种表型,这些表型代表了 LDL-C 降低百分比高于预期的患者的特征。此外,推导的表型的潜在表示形式实现了与使用原始数据获得的相似的预测性能。这些结果表明,推导的表型和潜在表示形式是观察患者特征和预测 LDL-C 水平的有用工具。此外,我们的研究结果为未来如何开展临床研究提供了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/5999101/b5b7db12842a/pone.0197518.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/5999101/b5b7db12842a/pone.0197518.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/5999101/b5b7db12842a/pone.0197518.g001.jpg

相似文献

1
Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization.使用张量分解对他汀类药物中等强度治疗效果优于预期的韩国患者进行表型分析。
PLoS One. 2018 Jun 13;13(6):e0197518. doi: 10.1371/journal.pone.0197518. eCollection 2018.
2
Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes.不同他汀类药物疗法对韩国糖尿病患者和非糖尿病患者低密度脂蛋白胆固醇及高密度脂蛋白胆固醇水平变化的比较。
J Clin Lipidol. 2016 May-Jun;10(3):528-537.e3. doi: 10.1016/j.jacl.2015.12.013. Epub 2015 Dec 23.
3
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.韩国人基线低密度脂蛋白胆固醇水平高于190mg/dL时使用中等强度他汀类药物的情况。
Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):272-278. doi: 10.1111/bcpt.12765. Epub 2017 Jul 9.
4
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.在真实临床实践环境中,将服用其他他汀类药物的患者换用瑞舒伐他汀或辛伐他汀后低密度脂蛋白胆固醇降低情况的比较。
Am J Manag Care. 2007 Dec;13 Suppl 10:S270-5.
5
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.依泽替米贝和辛伐他汀治疗高胆固醇血症减少动脉粥样硬化进展试验(ENHANCE)结果报告前后处方模式的变化,以及对降低低密度脂蛋白胆固醇的预期影响。
J Clin Lipidol. 2012 Mar-Apr;6(2):180-91. doi: 10.1016/j.jacl.2011.11.007. Epub 2011 Dec 7.
6
Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.在有糖尿病和无糖尿病的患者中,联合应用依折麦布/他汀类药物与单独应用他汀类药物相比,达到推荐的血脂和脂蛋白水平。
Diab Vasc Dis Res. 2011 Apr;8(2):160-72. doi: 10.1177/1479164111406457.
7
Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.比较阿托伐他汀和辛伐他汀对亚洲低密度脂蛋白胆固醇升高患者的疗效和安全性——一项多国、多中心、双盲研究。
J Formos Med Assoc. 2002 Jul;101(7):478-87.
8
Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.联合应用依折麦布和他汀类药物与他汀类药物双倍剂量单药治疗在高胆固醇血症患者中的疗效:文献荟萃分析。
Lipids Health Dis. 2020 Jan 4;19(1):1. doi: 10.1186/s12944-019-1182-5.
9
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.与其他他汀类药物相比,瑞舒伐他汀降低糖尿病患者低密度脂蛋白胆固醇的有效性及达到美国国家胆固醇教育计划成人治疗小组第三次指南低密度脂蛋白胆固醇目标的情况:一项使用美国电子病历数据集的回顾性研究
Curr Med Res Opin. 2007 Sep;23(9):2125-33. doi: 10.1185/030079907X219580.
10
Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia.两种他汀类药物在中国高胆固醇血症患者中实现特定血脂和高敏C反应蛋白水平的情况
Lipids Health Dis. 2015 Sep 13;14:107. doi: 10.1186/s12944-015-0116-0.

引用本文的文献

1
Data-Driven Phenotyping of Alzheimer's Disease under Epigenetic Conditions Using Partial Volume Correction of PET Studies and Manifold Learning.基于PET研究的部分容积校正和流形学习在表观遗传条件下进行阿尔茨海默病的数据驱动表型分析
Biomedicines. 2023 Jan 19;11(2):273. doi: 10.3390/biomedicines11020273.

本文引用的文献

1
Rubik: Knowledge Guided Tensor Factorization and Completion for Health Data Analytics.鲁比克:用于健康数据分析的知识引导张量分解与补全
KDD. 2015 Aug;2015:1265-1274. doi: 10.1145/2783258.2783395.
2
Federated Tensor Factorization for Computational Phenotyping.用于计算表型分析的联邦张量分解
KDD. 2017 Aug;2017:887-895. doi: 10.1145/3097983.3098118.
3
Smartphone dependence classification using tensor factorization.基于张量分解的智能手机依赖分类
PLoS One. 2017 Jun 21;12(6):e0177629. doi: 10.1371/journal.pone.0177629. eCollection 2017.
4
Discriminative and Distinct Phenotyping by Constrained Tensor Factorization.约束张量分解的判别和独特表型分析。
Sci Rep. 2017 Apr 25;7(1):1114. doi: 10.1038/s41598-017-01139-y.
5
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.韩国人基线低密度脂蛋白胆固醇水平高于190mg/dL时使用中等强度他汀类药物的情况。
Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):272-278. doi: 10.1111/bcpt.12765. Epub 2017 Jul 9.
6
Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea.韩国低强度和中等强度他汀类药物疗效的比较分析。
Int J Clin Pharmacol Ther. 2016 Nov;54(11):864-871. doi: 10.5414/CP202332.
7
Analysis and comparison of statin prescription patterns and outcomes according to clinical department.根据临床科室对他汀类药物处方模式及治疗结果进行分析与比较。
J Clin Pharm Ther. 2016 Feb;41(1):70-7. doi: 10.1111/jcpt.12350. Epub 2016 Jan 21.
8
(2) Classification and diagnosis of diabetes.(2) 糖尿病的分类与诊断。
Diabetes Care. 2015 Jan;38 Suppl:S8-S16. doi: 10.2337/dc15-S005.
9
Limestone: high-throughput candidate phenotype generation via tensor factorization.石灰岩:通过张量分解进行高通量候选表型生成。
J Biomed Inform. 2014 Dec;52:199-211. doi: 10.1016/j.jbi.2014.07.001. Epub 2014 Jul 16.
10
Statin Discontinuation after Achieving a Target Low Density Lipoprotein Cholesterol Level in Type 2 Diabetic Patients without Cardiovascular Disease: A Randomized Controlled Study.他汀类药物停药后在 2 型糖尿病患者无心血管疾病的目标低密脂蛋白胆固醇水平:一项随机对照研究。
Diabetes Metab J. 2014 Feb;38(1):64-73. doi: 10.4093/dmj.2014.38.1.64. Epub 2014 Feb 19.